Marco Quarta
Directeur Général chez Rubedo Life Sciences, Inc.
Postes actifs de Marco Quarta
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Rubedo Life Sciences, Inc.
 Rubedo Life Sciences, Inc. Packaged SoftwareTechnology Services Rubedo Life Sciences, Inc. develops intelligent drug platform to design unique, targeted and controlled therapies for age-related diseases. The company was founded by Marco Quarta, Mark Gallop and Julian Klein in 2018 and is headquartered in Silicon Valley, CA. | Directeur Général | 01/01/2018 | - |
| Fondateur | 01/01/2018 | - | |
Turn Biotechnologies, Inc.
 Turn Biotechnologies, Inc. BiotechnologyHealth Technology Turn Biotechnologies, Inc. engages in the development of solutions for reversing aging and age-related diseases. It focuses on achieving rejuvenation across cellular aging hallmarks in human fibroblasts and endothelial cells without the loss cellular identity. The company was founded by Jay Sarkar, Marco Quarta, and Vittorio Sebastiano and is headquartered in Mountain View, CA. | Directeur Technique/Scientifique/R&D | - | - |
| Fondateur | - | - |
Historique de carrière de Marco Quarta
Statistiques
Internationale
| Etats-Unis | 3 |
Opérationnelle
| Founder | 2 |
| Chief Executive Officer | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectorielle
| Technology Services | 2 |
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Rubedo Life Sciences, Inc.
Rubedo Life Sciences, Inc. Packaged SoftwareTechnology Services Rubedo Life Sciences, Inc. develops intelligent drug platform to design unique, targeted and controlled therapies for age-related diseases. The company was founded by Marco Quarta, Mark Gallop and Julian Klein in 2018 and is headquartered in Silicon Valley, CA. | Technology Services |
Turn Biotechnologies, Inc.
Turn Biotechnologies, Inc. BiotechnologyHealth Technology Turn Biotechnologies, Inc. engages in the development of solutions for reversing aging and age-related diseases. It focuses on achieving rejuvenation across cellular aging hallmarks in human fibroblasts and endothelial cells without the loss cellular identity. The company was founded by Jay Sarkar, Marco Quarta, and Vittorio Sebastiano and is headquartered in Mountain View, CA. | Health Technology |
- Bourse
- Insiders
- Marco Quarta
- Expérience
